Hatteras Venture Partners related stories
All articles and analysis
Viamet Pharma Raises $18 MillionViamet Pharmaceuticals Inc., a Morrisville, N.C.-based biotech company targeting metalloenzymes, has raised $18 million in Series B funding. Novartis Option Fund and Lilly Ventures co-led the round, and were joined by return backers Intersouth Partners, Hatteras Venture Partners, Lurie Investment Fund and Astellas Venture Management.
- Pathfinder Raises $5 Million
Pathfinder Therapeutics Inc., a Nashville, Tenn.-based developer of a “surgical GPS” systems for the abdomen, has raised $5.2 million in Series A funding. Hatteras Venture Partners led the round, and was joined by Florida Gulfshore Capital, Clayton & Associates, Nashville Capital Network, Lumira and Vanderbilt University.
- PE Week Wire: Friday, October 31, 2008
Private Equity as Footwear
- PE Week Wire: Friday, October 31, 2008
Private Equity as Footwear
- Executive moves, week of May 26, 2008
Hires and promotions at VantagePoint, Battery Ventures, Indigo Capital and other VC and PE firms
- PE Week Wire: Wed., May 21, 2008
How (Not) To Raise Venture Capital
- PE Week Wire: Wed., May 21, 2008
How (Not) To Raise Venture Capital